Cannabis Law Report
JULY 9, 2021
This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. As part of the same state-wide initiative, Oregon legalized the use of psilocybin for medical purposes. Id ; 21 CFR 312.1-10; 10; 312.80-88;
The Cannigma
AUGUST 14, 2022
A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. Type I cannabis products are the most popular on the legal market, but they shouldn’t be your first choice for focus and reaching a flow state. But this isn’t the only area of the brain affected by cannabis consumption.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.
Cannabis Law Report
JULY 25, 2022
Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. It was certainly presented as that if this became legal in Australia … that Mind Medicine were the ones who would be certifying people. “I
Cannabis Law Report
JUNE 10, 2021
In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. Support for per-se laws was higher among those in states that legalized recreational marijuana and in states with per-se laws. RM and MM Legal vs. 82.6%
Cannabis Law Report
APRIL 8, 2022
as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Now, we are closer than ever to legalizing MDMA-assisted therapy for posttraumatic stress disorder (PTSD), though there is still a long road ahead. Rick Doblin, Ph.D., Rick Doblin, Ph.D.,
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.
Expert insights. Personalized for you.
105 
Let's personalize your content